Literature DB >> 15354305

MR imaging of the prostate at 3 Tesla: comparison of an external phased-array coil to imaging with an endorectal coil at 1.5 Tesla.

Jacob Sosna1, Ivan Pedrosa, William C Dewolf, Houman Mahallati, Robert E Lenkinski, Neil M Rofsky.   

Abstract

RATIONALE AND
OBJECTIVES: To qualitatively compare the image quality of torso phased-array 3-Tesla (3T) imaging of the prostate with that of endorectal 1.5-Tesla imaging.
MATERIALS AND METHODS: Twenty cases of torso phased-array prostate imaging performed at 3-Tesla with FSE T2 weighted images were evaluated by two readers independently for visualization of the posterior border (PB), seminal vesicles (SV), neurovascular bundles (NVB), and image quality rating (IQR). Studies were performed at large fields of view(FOV) (25 cm) (14 cases) (3TL) and smaller FOV (14 cm) (19 cases) (3TS). A comparison was made to 20 consecutive cases of 1.5-T endorectal evaluation performed during the same time period.Results. 3TL produced a significantly better image quality compared with the small FOV for PB (P = .0001), SV (P =.0001), and IQR (P = .0001). There was a marginally significant difference within the NVB category (P = .0535). 3TL produced an image of similar quality to image quality at 1.5 T for PB (P = .3893), SV (P = .8680), NB (P = .2684), and IQR (P = .8599).
CONCLUSION: Prostate image quality at 3T with a torso phased-array coil can be comparable with that of endorectal 1.5-T imaging. These findings suggest that additional options are now available for magnetic resonance imaging of the prostate gland.

Entities:  

Mesh:

Year:  2004        PMID: 15354305     DOI: 10.1016/j.acra.2004.04.013

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  33 in total

Review 1.  Technological advances in radiation therapy for prostate cancer.

Authors:  Mehee Choi; Arthur Y Hung
Journal:  Curr Urol Rep       Date:  2010-05       Impact factor: 3.092

Review 2.  Whole-body MRI at high field: technical limits and clinical potential.

Authors:  Fritz Schick
Journal:  Eur Radiol       Date:  2005-01-27       Impact factor: 5.315

Review 3.  Prostate MR imaging at high-field strength: evolution or revolution?

Authors:  Olivier Rouvière; Robert P Hartman; Denis Lyonnet
Journal:  Eur Radiol       Date:  2005-09-10       Impact factor: 5.315

4.  [MR techniques for noninvasive diagnosis of prostate cancer].

Authors:  N Morakkabati-Spitz; P J Bastian; A Meissner; F Träber; J Gieseke; H H Schild; S C Müller
Journal:  Urologe A       Date:  2006-06       Impact factor: 0.639

5.  Preoperative staging of rectal cancer: accuracy of 3-Tesla magnetic resonance imaging.

Authors:  Chan Kyo Kim; Seung Hoon Kim; Ho Kyung Chun; Woo-Yong Lee; Seong-Hyeon Yun; Sang-Yong Song; Dongil Choi; Hyo Keun Lim; Min Ju Kim; Jongmee Lee; Soon Jin Lee
Journal:  Eur Radiol       Date:  2006-01-17       Impact factor: 5.315

6.  Software strategy for robotic transperineal prostate therapy in closed-bore MRI.

Authors:  Junichi Tokuda; Gregory S Fischer; Csaba Csoma; Simon P DiMaio; David G Gobbi; Gabor Fichtinger; Clare M Tempany; Nobuhiko Hata
Journal:  Med Image Comput Comput Assist Interv       Date:  2008

Review 7.  Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer.

Authors:  Antonio C Westphalen; David A McKenna; John Kurhanewicz; Fergus V Coakley
Journal:  J Endourol       Date:  2008-04       Impact factor: 2.942

Review 8.  Contemporary issues in the diagnosis of prostate cancer for the radiologist.

Authors:  Richard Clements
Journal:  Eur Radiol       Date:  2006-04-01       Impact factor: 5.315

Review 9.  Clinical applications for diffusion magnetic resonance imaging in radiotherapy.

Authors:  Christina Tsien; Yue Cao; Thomas Chenevert
Journal:  Semin Radiat Oncol       Date:  2014-07       Impact factor: 5.934

Review 10.  Role of Multiparametric MR Imaging in Malignancies of the Urogenital Tract.

Authors:  Alberto Diaz de Leon; Daniel Costa; Ivan Pedrosa
Journal:  Magn Reson Imaging Clin N Am       Date:  2016-02       Impact factor: 2.266

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.